These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3324526)

  • 61. [Calcium antagonists in hypertrophic cardiomyopathy].
    Nartowicz E; Ukleja-Adamowicz M
    Pol Tyg Lek; 1988 Oct; 43(44):1395-8. PubMed ID: 3252203
    [No Abstract]   [Full Text] [Related]  

  • 62. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration.
    Rosing DR; Condit JR; Maron BJ; Kent KM; Leon MB; Bonow RO; Lipson LC; Epstein SE
    Am J Cardiol; 1981 Sep; 48(3):545-53. PubMed ID: 7196690
    [No Abstract]   [Full Text] [Related]  

  • 63. Obstructive hypertrophic cardiomyopathy with left-sided cardiac failure: improvement after verapamil treatment.
    Eldar M; Hod H; Battler A; Rotstein Z; Feldman S; Rabinowitz B; Neufeld HN
    Am J Cardiol; 1984 Feb; 53(4):644-5. PubMed ID: 6538062
    [No Abstract]   [Full Text] [Related]  

  • 64. Surgical versus medical therapy of hypertrophic cardiomyopathy: is the perspective changing?
    Chahine RA
    J Am Coll Cardiol; 1991 Mar; 17(3):643-5. PubMed ID: 1993781
    [No Abstract]   [Full Text] [Related]  

  • 65. A reduction in verapamil concentrations with phenytoin.
    Woodcock BG; Kirsten R; Nelson K; Rietbrock S; Hopf R; Kaltenbach M
    N Engl J Med; 1991 Oct; 325(16):1179. PubMed ID: 1891033
    [No Abstract]   [Full Text] [Related]  

  • 66. Medical and surgical treatment of hypertrophic cardiomyopathy.
    Goodwin JF; Oakley CM
    Eur Heart J; 1983 Nov; 4 Suppl F():209-14. PubMed ID: 6686537
    [No Abstract]   [Full Text] [Related]  

  • 67. Symptomatic Japanese-type apical hypertrophic cardiomyopathy in a non-Asian patient: favorable response to treatment with verapamil.
    Zack PM; Blausey WL
    Am Heart J; 1994 Sep; 128(3):613-6. PubMed ID: 8074027
    [No Abstract]   [Full Text] [Related]  

  • 68. Therapy of hypertrophic cardiomyopathy: medical or surgical? clinical and pathophysiologic considerations.
    Canedo MI; Frank MJ
    Am J Cardiol; 1981 Aug; 48(2):383-8. PubMed ID: 6115580
    [No Abstract]   [Full Text] [Related]  

  • 69. Verapamil and norverapamil plasma concentrations during long-term therapy in patients with hypertrophic obstructive cardiomyopathy.
    Woodcock BG; Hopf R; Kaltenbach M
    J Cardiovasc Pharmacol; 1980; 2(1):17-23. PubMed ID: 6154201
    [No Abstract]   [Full Text] [Related]  

  • 70. Long-term follow-up of the primary hyperkinetic heart syndrome. An echocardiographic and hemodynamic study.
    Fiorentini C; Olivari MT; Moruzzi P; Guazzi MD
    Am J Med; 1981 Aug; 71(2):221-7. PubMed ID: 7196153
    [No Abstract]   [Full Text] [Related]  

  • 71. Propranolol and arrhythmia in hypertrophic cardiomyopathy.
    Canedo MI; Frank MJ; Abdulla AM
    Am J Cardiol; 1980 Oct; 46(4):704-5. PubMed ID: 7191199
    [No Abstract]   [Full Text] [Related]  

  • 72. Potential macrolide interaction with verapamil.
    Steenbergen JA; Stauffer VL
    Ann Pharmacother; 1998 Mar; 32(3):387-8. PubMed ID: 9533073
    [No Abstract]   [Full Text] [Related]  

  • 73. Bizarre perceptual disorder of extremities in patients taking verapamil.
    Kumana CR; Mahon WA
    Lancet; 1981 Jun; 1(8233):1324-5. PubMed ID: 6112646
    [No Abstract]   [Full Text] [Related]  

  • 74. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
    Lösse B; Loogen F; Schulte HD
    Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy].
    Crittin J; Mayor C; Bloch A
    Ann Cardiol Angeiol (Paris); 1984 Apr; 33(3):185-9. PubMed ID: 6375537
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Changes of the degree of hypertrophy in hypertrophic obstructive cardiomyopathy under medical and surgical treatment.
    Curtius JM; Stoecker J; Loesse B; Welslau R; Scholz D
    Cardiology; 1989; 76(4):255-63. PubMed ID: 2529965
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study.
    Kober G; Hopf R; Biamino G; Bubenheimer P; Förster K; Kuck KH; Hanrath P; von Olshausen KE; Schlepper M; Kaltenbach M
    Z Kardiol; 1987; 76 Suppl 3():113-8. PubMed ID: 3324526
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.